Immunogenicity and protective efficacy of an intranasal live-attenuated vaccine against SARS-CoV-2
Article
[키워드] Abstract
acute respiratory syndrome
administration
antibody
caused
clinical disease
Complete
coronavirus
coronavirus disease
COVID-19
COVID-19 pandemic
curtail
dose
effective
Efficacy
evaluated
expressing
hamster
hamsters
IgA
IgG2a
immunized
immunogenicity
immunoglobulin A
immunology
induce
Infection
Inflammation
intranasal
lesion
live-attenuated vaccine
lung
Lung infection
Lung inflammation
mice
nasal
nasal turbinate
Neutralizing
newcastle disease virus
pathology
Prevent
Protective
Protein
reduced
Safe
SARS-CoV-2
significantly
Spread
T-cell-mediated immunity
the SARS-CoV-2
undetectable
vaccination
Vaccine
Virology
virus transmission
[DOI] 10.1016/j.isci.2021.102941 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/j.isci.2021.102941 PMC 바로가기 [Article Type] Article